This is a StreetInsider.com Premium Only Page

BioMarin Pharma (BMRN) – StreetInsider.com Reports

Apr 22, 2024 12:03 PM UBS Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)

Apr 22, 2024 03:57 AM Increasing unusual put option volume: INFY PZZA MUB STNE IP IBL ALTM SPCE GEO BMRN

Apr 15, 2024 04:48 PM Truist Securities Assumes BioMarin Pharmaceutical Inc. (BMRN) at Buy

Mar 8, 2024 03:23 PM BioMarin Pharma (BMRN) April 80 puts active

Mar 7, 2024 08:31 AM BioMarin Pharma (BMRN) Appoints Cristin Hubbard as Chief Commercial Officer

Feb 23, 2024 02:58 PM BioMarin Pharma (BMRN) April 85 puts active

Feb 23, 2024 09:52 AM Increasing unusual option volume: SANA HUYA BMRN INDI CYH FTAI NU FTI

Feb 23, 2024 08:54 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $115 at Morgan Stanley

Feb 23, 2024 08:00 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $128 at Jefferies

Feb 23, 2024 07:03 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $107 at Piper Sandler

Feb 23, 2024 03:43 AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $94 at Citi

Feb 22, 2024 04:05 PM BioMarin Pharma (BMRN) Tops Q4 EPS by 29c ; Offers Guidance

Feb 20, 2024 07:47 AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $133 at Jefferies

Feb 12, 2024 03:27 PM BioMarin Pharma (BMRN) March 80 puts active

Jan 30, 2024 06:19 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $104 at Baird

Jan 11, 2024 04:11 PM BioMarin Pharma (BMRN) Announces Resignation of Chief Commercial Officer

Jan 2, 2024 01:56 AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $93 at Bernstein

Dec 20, 2023 04:06 PM BioMarin Pharma (BMRN) Announces Governance Enhancements and Value Creation Initiatives

Nov 28, 2023 08:32 AM BioMarin Pharma (BMRN) Agreement with German Health Insurance Fund on Reimbursement Amount for ROCTAVIAN for Severe Hemophilia A in Germany

Nov 15, 2023 05:09 AM Wells Fargo Starts BioMarin Pharmaceutical Inc. (BMRN) at Overweight

Nov 8, 2023 07:31 AM Goldman explores intrinsic and takeover value of BioMarin amid Elliott stake

Nov 7, 2023 09:23 AM BioMarin Pharma (BMRN) gains on report Elliott has a stake

Nov 7, 2023 08:58 AM Activist Investor Elliott Takes Stake In Biomarin Pharmaceutical (BMRN), In Talks With Company About Its Future - Reuters

Nov 7, 2023 07:22 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $91 at Canaccord Genuity

Nov 3, 2023 04:14 PM BioMarin Pharma (BMRN) Announces CEO Resignation

Nov 2, 2023 09:41 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $170 at BofA Securities

Nov 2, 2023 09:17 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $117 at Morgan Stanley

Nov 2, 2023 08:47 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $119 at UBS

Nov 2, 2023 08:39 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $101 at Stifel

Nov 2, 2023 07:58 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $106 at Jefferies

Nov 2, 2023 07:55 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $125 at TD Cowen

Nov 2, 2023 07:09 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $83 at Scotiabank

Nov 2, 2023 06:41 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $100 at BMO Capital

Nov 2, 2023 06:33 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $100 at Cantor Fitzgerald

Nov 2, 2023 06:28 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $115 at Piper Sandler

Nov 1, 2023 04:16 PM BioMarin Pharma (BMRN) Tops Q3 EPS by 23c; offers guidance

Nov 1, 2023 04:02 PM BioMarin Pharma (BMRN) Announces CEO Retirement

Oct 23, 2023 05:40 AM Bernstein Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Market Perform

Oct 20, 2023 04:05 PM BioMarin Pharma (BMRN) Announces FDA Approval of VOXZOGO for Children Under 5 Years with Achondroplasia

Oct 6, 2023 09:58 AM Increasing unusual option volume

Sep 28, 2023 06:27 AM Raymond James Starts BioMarin Pharmaceutical Inc. (BMRN) at Market Perform, 'Cautious on Roctavian's Outlook & Few Near-Term Catalysts'

Sep 18, 2023 04:42 AM UBS Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy, 'Undervalued sustainable profits'

Sep 15, 2023 09:29 AM BioMarin Pharma (BMRN) Receives Positive CHMP Opinion in Europe to Expand Use of VOXZOGO to Treat Children Aged 4 Months and Older with Achondroplasia

Aug 1, 2023 08:45 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $125 at Morgan Stanley

Aug 1, 2023 07:39 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $108 at Stifel

Aug 1, 2023 06:57 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $70 at Wedbush

Jul 31, 2023 04:05 PM BioMarin Pharma (BMRN) Tops Q2 EPS by 31c, Offers Guidance

Jul 27, 2023 05:04 AM Scotiabank Starts BioMarin Pharmaceutical Inc. (BMRN) at Sector Perform

Jul 21, 2023 06:00 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $185 at BofA Securities

Jul 11, 2023 07:28 AM BioMarin (BMRN) Dropped from BofA Securities Best Ideas List